Literature DB >> 4551948

A review of studies on the mode of action of clofibrate and betabenzalbutyrate.

H J Fallon, L L Adams, R G Lamb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4551948     DOI： 10.1007/bf02532596

Source DB:  PubMed          Journal:  Lipids        ISSN： 0024-4201            Impact factor:   1.880


× No keyword cloud information.
  28 in total

1.  AN EXPERIMENTAL APPROACH TO THE PROBLEM OF DISORDERED LIPID METABOLISM.

Authors:  J M THORP
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

2.  HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.

Authors:  M M BEST; C H DUNCAN
Journal:  J Lab Clin Med       Date:  1964-10

3.  Reduction of serum-lipid and uric-acid levels by an orally active androsterone.

Authors:  M F OLIVER
Journal:  Lancet       Date:  1962-06-23       Impact factor: 79.321

4.  An enzymatic fluorometric micromethod for the determination of glycerol.

Authors:  S Laurell; G Tibbling
Journal:  Clin Chim Acta       Date:  1966-03       Impact factor: 3.786

5.  The role of the thyroid hormone in the effect of p-chlorophenoxyisobutyrate in rats.

Authors:  W W Westerfeld; D A Richert; W R Ruegamer
Journal:  Biochem Pharmacol       Date:  1968-06       Impact factor: 5.858

6.  Effect of CPIB ester on plasma free fatty acid levels in man.

Authors:  B M Rifkind
Journal:  Metabolism       Date:  1966-08       Impact factor: 8.694

7.  The formation of monoacylglycerophosphate from sn-glycerol 3-phosphate by a rat liver particulate preparation.

Authors:  R G Lamb; H J Fallon
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

8.  Growth and liver glycerophosphate dehydrogenase response to thyroxine and p-chlorophenoxyisobutyrate.

Authors:  D A Richert; W W Westerfeld
Journal:  Endocrinology       Date:  1970-12       Impact factor: 4.736

9.  Effects of selected hypolipidemic drugs on cell ultrastructure.

Authors:  D J Svoboda; D L Azarnoff
Journal:  Fed Proc       Date:  1971 May-Jun

10.  Hyperlipaemia in experimental nephrosis and its control by chlorophenoxyisobutyrate and betabenzalbutyrate.

Authors:  K D Edwards; R Paoletti
Journal:  Med J Aust       Date:  1970-03-07       Impact factor: 7.738
View more
  7 in total

1.  The increased rate of ethanol removal from blood of clofibrate-treated rats.

Authors:  R A Hawkins; R C Nielsen; R L Veech
Journal:  Biochem J       Date:  1974-04       Impact factor: 3.857

2.  Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model.

Authors:  H A Newman; W P Heilman; D T Witiak
Journal:  Lipids       Date:  1973-07       Impact factor: 1.880

3.  Drugs affecting the synthesis of glycerides and phospholipids in rat liver. The effects of clofibrate, halofenate, fenfluramine, amphetamine, cinchocaine, chlorpromazine, demethylimipramine, mepyramine and some of their derivatives.

Authors:  D N Brindley; M Bowley
Journal:  Biochem J       Date:  1975-06       Impact factor: 3.857

4.  Alterations in cholesterol and fatty acid biosynthesis in rat liver homogenates by aryloxy acids.

Authors:  R J Olson; T E Trumble; W Gamble
Journal:  Biochem J       Date:  1974-08       Impact factor: 3.857

5.  Antiviral activity of antilipidemic compounds on herpes simplex virus type 1.

Authors:  J K Mehl; D T Witiak; V V Hamparian; J H Hughes
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

6.  The tritium isotope effect of sn-glycerol 3-phosphate oxidase and the effects of clofenapate and N-(2-benzoyloxyethyl)norfenfluramine on the esterification of glycerol phosphate and dihydroxyacetone phosphate by rat liver mitochondria.

Authors:  M Bowley; R Manning; D N Brindlay
Journal:  Biochem J       Date:  1973-10       Impact factor: 3.857

7.  Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo.

Authors:  H D Mulligan; M J Tisdale
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.